Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michele Fox

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
31
2023
577
2.220
Why?
Hematopoietic Stem Cells
21
2018
197
1.930
Why?
Multiple Myeloma
44
2024
2998
1.830
Why?
Bone Marrow Transplantation
27
2016
136
1.790
Why?
Hematopoietic Stem Cell Mobilization
13
2018
58
1.440
Why?
Antigens, CD34
20
2018
75
0.980
Why?
Antineoplastic Combined Chemotherapy Protocols
16
2024
1000
0.900
Why?
Cell Separation
8
2013
92
0.810
Why?
Blood Platelets
5
2017
251
0.800
Why?
Purpura, Thrombotic Thrombocytopenic
3
2018
16
0.720
Why?
Melphalan
7
2016
178
0.610
Why?
Leukapheresis
5
2018
17
0.590
Why?
Transplantation, Autologous
21
2013
481
0.580
Why?
Fetal Blood
4
2023
66
0.580
Why?
Myelodysplastic Syndromes
3
2013
78
0.550
Why?
Graft vs Host Disease
15
2003
84
0.520
Why?
Leukocytes, Mononuclear
5
2018
118
0.500
Why?
Plasma Exchange
3
2015
25
0.490
Why?
Humans
89
2024
50578
0.480
Why?
Adult
47
2019
13604
0.450
Why?
Middle Aged
42
2018
12615
0.440
Why?
Flow Cytometry
6
2016
474
0.420
Why?
Aged
32
2017
9747
0.410
Why?
Transplantation Conditioning
9
2006
87
0.400
Why?
Granulocyte Colony-Stimulating Factor
7
2012
63
0.390
Why?
Killer Cells, Natural
3
2015
106
0.390
Why?
Pregnant Women
1
2023
74
0.390
Why?
Blood Component Removal
4
2018
10
0.390
Why?
Female
49
2023
27148
0.370
Why?
Chromosome Aberrations
5
2016
280
0.360
Why?
Cell Proliferation
5
2018
985
0.350
Why?
Male
46
2019
25923
0.350
Why?
Immunotherapy, Adoptive
2
2015
163
0.340
Why?
Transplantation, Homologous
13
2016
145
0.340
Why?
Platelet Count
4
2017
65
0.340
Why?
Antigens, CD
10
2003
222
0.330
Why?
Blood Transfusion
3
2017
129
0.330
Why?
Thalidomide
5
2016
378
0.330
Why?
Blood Specimen Collection
1
2019
35
0.320
Why?
Antibodies
2
2016
153
0.320
Why?
Blood Volume
1
2019
69
0.310
Why?
Education, Distance
1
2019
42
0.310
Why?
Erythrocyte Transfusion
3
2015
52
0.300
Why?
Clinical Laboratory Techniques
1
2018
28
0.300
Why?
Cryopreservation
3
2010
33
0.300
Why?
Lymphoma
3
2018
67
0.290
Why?
Obstetrics
1
2019
86
0.290
Why?
Leukemia
3
2013
65
0.290
Why?
Cyclooxygenase Inhibitors
1
2017
38
0.280
Why?
Blood Grouping and Crossmatching
1
2017
5
0.280
Why?
Blood Coagulation
1
2017
60
0.280
Why?
Leukocytes
3
2011
69
0.270
Why?
Bone Marrow Cells
5
2004
196
0.270
Why?
Graft Survival
7
2011
159
0.270
Why?
Follow-Up Studies
11
2024
2243
0.270
Why?
Aspirin
1
2017
112
0.260
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
121
0.260
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
2000
45
0.260
Why?
Platelet Aggregation Inhibitors
1
2017
174
0.250
Why?
Combined Modality Therapy
12
2014
641
0.240
Why?
Hemoglobins, Abnormal
1
2015
4
0.240
Why?
Heparin
1
2015
91
0.240
Why?
Thrombocytopenia
1
2015
81
0.240
Why?
Stem Cell Transplantation
2
2013
179
0.240
Why?
Factor VIII
1
2014
23
0.230
Why?
ADAM Proteins
1
2014
20
0.230
Why?
Methotrexate
2
2001
72
0.230
Why?
Anemia, Sickle Cell
1
2015
94
0.220
Why?
Cancer Vaccines
3
2010
80
0.220
Why?
Internship and Residency
1
2019
447
0.220
Why?
Dendritic Cells
3
2010
135
0.210
Why?
Prognosis
8
2018
1978
0.210
Why?
Retroviridae
4
1997
9
0.210
Why?
Retrospective Studies
11
2018
6272
0.210
Why?
Neoplasm Recurrence, Local
3
2015
629
0.210
Why?
Cell Count
7
2011
150
0.210
Why?
Antiretroviral Therapy, Highly Active
1
2013
32
0.210
Why?
Cytomegalovirus Infections
3
2001
38
0.210
Why?
Cell Survival
7
2011
589
0.200
Why?
Afibrinogenemia
1
2012
5
0.200
Why?
Bone Marrow
8
1997
363
0.200
Why?
Dexamethasone
6
2024
432
0.200
Why?
Graft vs Tumor Effect
2
2006
3
0.200
Why?
Treatment Outcome
19
2013
5284
0.190
Why?
Leukemia, Myeloid
2
2000
44
0.190
Why?
Adenoviridae Infections
1
2001
3
0.190
Why?
Aldehyde Dehydrogenase
1
2011
25
0.190
Why?
Gene Transfer Techniques
3
1997
41
0.190
Why?
Lung Diseases, Fungal
1
2001
19
0.190
Why?
Tamoxifen
1
2001
60
0.190
Why?
Cyclophosphamide
8
2006
168
0.180
Why?
Boronic Acids
2
2013
183
0.180
Why?
Pyrazines
2
2013
188
0.180
Why?
Plateletpheresis
1
2010
7
0.180
Why?
Blood Preservation
1
2010
26
0.180
Why?
Lymphoma, B-Cell
1
2000
49
0.170
Why?
Immunosuppressive Agents
4
2014
225
0.170
Why?
Blood Proteins
1
2010
84
0.170
Why?
Myeloablative Agonists
3
2007
32
0.170
Why?
Fever
1
2001
112
0.170
Why?
Peripheral Blood Stem Cell Transplantation
3
2006
56
0.170
Why?
Anaphylaxis
1
2010
69
0.170
Why?
Genetic Vectors
4
1997
128
0.160
Why?
Chromosomes, Human, Pair 1
2
2007
92
0.160
Why?
Blood Cells
4
1994
47
0.160
Why?
Incidence
7
2017
1032
0.160
Why?
HIV Infections
1
2013
352
0.160
Why?
Receptors, KIR
1
2008
13
0.160
Why?
Etoposide
6
2006
77
0.160
Why?
Gene Expression Regulation, Neoplastic
2
2016
833
0.150
Why?
Disease-Free Survival
6
2016
444
0.150
Why?
Cell Movement
2
2006
247
0.140
Why?
Phosphotransferases (Alcohol Group Acceptor)
2
1995
23
0.140
Why?
Immunoglobulins, Intravenous
3
1992
65
0.140
Why?
Lymphocyte Transfusion
3
2003
12
0.140
Why?
Risk Factors
7
2015
3724
0.130
Why?
Breast Neoplasms
6
1995
1200
0.130
Why?
Models, Genetic
1
2006
172
0.130
Why?
Osteogenesis
2
2006
356
0.130
Why?
Transformation, Genetic
1
1995
18
0.130
Why?
Models, Statistical
1
2007
226
0.130
Why?
Antineoplastic Agents
5
2012
1172
0.130
Why?
Young Adult
4
2019
4113
0.130
Why?
Time Factors
2
2010
2939
0.120
Why?
Cytokines
2
2006
606
0.120
Why?
Gene Expression Profiling
2
2007
1025
0.120
Why?
Macrophages
1
2018
364
0.120
Why?
Metaphase
3
2016
45
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
1995
76
0.120
Why?
Dimethyl Sulfoxide
2
2010
13
0.120
Why?
Recurrence
4
2008
659
0.120
Why?
Mycobacterium tuberculosis
1
2007
266
0.120
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
234
0.120
Why?
CD8-Positive T-Lymphocytes
1
1995
125
0.120
Why?
Models, Biological
2
2007
716
0.120
Why?
Risk
2
2017
324
0.120
Why?
Immunoglobulin G
3
2003
190
0.120
Why?
Acute Disease
4
2013
373
0.120
Why?
Postoperative Complications
2
2001
1034
0.110
Why?
CD4-Positive T-Lymphocytes
1
1995
158
0.110
Why?
Pregnancy
2
2023
2504
0.110
Why?
Cytotoxicity Tests, Immunologic
2
2016
27
0.110
Why?
Blood Banks
1
2023
17
0.110
Why?
Sweet Syndrome
1
2003
11
0.110
Why?
Neoplasms
4
2007
1252
0.100
Why?
Bone Diseases
1
2004
96
0.100
Why?
Osteoblasts
1
2006
462
0.100
Why?
Cyclosporine
1
2003
66
0.100
Why?
Prospective Studies
6
2016
2383
0.100
Why?
Tacrolimus
1
2003
53
0.100
Why?
Hemorrhage
2
2017
197
0.100
Why?
Blood Group Incompatibility
1
2002
5
0.100
Why?
ABO Blood-Group System
1
2002
15
0.100
Why?
Universities
1
2023
170
0.100
Why?
T-Lymphocytes
2
1998
325
0.100
Why?
Kaplan-Meier Estimate
3
2007
464
0.100
Why?
Coculture Techniques
3
2018
142
0.100
Why?
Ovarian Neoplasms
1
1995
450
0.090
Why?
Genetic Therapy
3
1995
120
0.090
Why?
Lymphoma, Mantle-Cell
2
2001
14
0.090
Why?
Cryoprotective Agents
2
1998
8
0.090
Why?
Hodgkin Disease
2
2002
47
0.090
Why?
Osteoclasts
1
2004
427
0.090
Why?
Platelet Transfusion
2
2010
29
0.090
Why?
Lymphocyte Depletion
3
1996
9
0.090
Why?
Tissue Preservation
2
1998
8
0.090
Why?
Cyclosporins
2
1991
11
0.090
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2012
56
0.090
Why?
T-Lymphocytes, Cytotoxic
1
2010
63
0.090
Why?
Tissue Donors
3
2003
121
0.080
Why?
Heart Failure
1
2006
528
0.080
Why?
Thrombosis
1
2003
250
0.080
Why?
Vaccines, DNA
1
1999
12
0.080
Why?
Erythroid Precursor Cells
1
2019
15
0.080
Why?
Logistic Models
3
2017
899
0.080
Why?
Reproducibility of Results
3
2017
1203
0.080
Why?
Cisplatin
4
2006
286
0.080
Why?
Birth Weight
1
2019
106
0.080
Why?
Graft vs Host Reaction
1
1998
1
0.080
Why?
Antigens, Neoplasm
2
2005
148
0.080
Why?
Hematocrit
1
2018
43
0.070
Why?
Survival Analysis
6
2006
661
0.070
Why?
Salvage Therapy
3
2003
137
0.070
Why?
Medical Waste
1
2017
2
0.070
Why?
Cell Aggregation
1
2017
6
0.070
Why?
Antineoplastic Agents, Alkylating
2
2008
73
0.070
Why?
Neutrophils
2
2006
145
0.070
Why?
Program Evaluation
1
2019
350
0.070
Why?
Arkansas
2
2017
1991
0.070
Why?
Lymphoma, Follicular
1
2017
21
0.070
Why?
Neoplasm Proteins
2
2016
320
0.070
Why?
Histocompatibility Antigens Class I
1
2017
46
0.070
Why?
Lymphocyte Activation
2
1995
164
0.070
Why?
Antibodies, Monoclonal
2
2002
462
0.070
Why?
Infant, Newborn
2
2019
2768
0.070
Why?
Fibrosis
1
2017
181
0.070
Why?
Adolescent
5
2015
6447
0.070
Why?
Reticulocyte Count
1
2006
5
0.070
Why?
Dose-Response Relationship, Drug
3
2008
1372
0.060
Why?
Tumor Escape
1
2006
17
0.060
Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
90
0.060
Why?
Curriculum
1
2019
400
0.060
Why?
Mice
5
2018
5687
0.060
Why?
Prostatic Neoplasms
1
1999
384
0.060
Why?
Glucosylceramidase
1
1995
9
0.060
Why?
Membrane Glycoproteins
3
2004
245
0.060
Why?
Cytogenetic Analysis
2
2007
74
0.060
Why?
Neutropenia
1
2006
116
0.060
Why?
Hemoglobin J
1
2015
3
0.060
Why?
Hemoglobin, Sickle
1
2015
6
0.060
Why?
Hemoglobin C
1
2015
6
0.060
Why?
Hematologic Neoplasms
1
1996
99
0.060
Why?
Clinical Protocols
2
2012
110
0.060
Why?
Blood Donors
1
2015
32
0.060
Why?
Aged, 80 and over
3
2013
3227
0.060
Why?
Diagnosis, Differential
1
2018
1033
0.060
Why?
Cell Line
2
2008
988
0.060
Why?
Tumor Necrosis Factor-alpha
2
2007
393
0.060
Why?
Animals
7
2018
13125
0.060
Why?
Base Sequence
3
1995
639
0.060
Why?
Autoantibodies
1
2014
117
0.050
Why?
Age Factors
3
2005
1111
0.050
Why?
Specimen Handling
1
1994
55
0.050
Why?
Whole-Body Irradiation
4
1998
132
0.050
Why?
Molecular Sequence Data
3
1995
778
0.050
Why?
Multivariate Analysis
3
2007
583
0.050
Why?
Blotting, Western
1
2015
578
0.050
Why?
Prednisone
2
2000
101
0.050
Why?
Feasibility Studies
2
2011
394
0.050
Why?
Interferon-gamma
2
2010
177
0.050
Why?
CD4 Lymphocyte Count
1
2013
32
0.050
Why?
Quality Assurance, Health Care
1
1994
150
0.050
Why?
Pulmonary Fibrosis
2
1991
19
0.050
Why?
Viral Load
1
2013
76
0.050
Why?
Immunization, Passive
1
1992
30
0.050
Why?
Transplantation Chimera
3
2003
14
0.050
Why?
Pharmacokinetics
1
1992
17
0.050
Why?
Cohort Studies
3
2006
1456
0.050
Why?
Haplotypes
2
2008
83
0.050
Why?
Bone Marrow Purging
1
1992
2
0.050
Why?
Infection Control
1
1992
47
0.050
Why?
Benzylamines
1
2012
15
0.050
Why?
Receptors, CXCR4
1
2012
30
0.050
Why?
Immunoglobulins
1
1992
81
0.050
Why?
Immunohistochemistry
1
2015
957
0.050
Why?
Recombinant Proteins
2
2008
476
0.050
Why?
Heterocyclic Compounds
1
2012
29
0.050
Why?
Urine
1
1991
24
0.050
Why?
Kanamycin Kinase
2
1995
2
0.050
Why?
Carmustine
1
2001
14
0.050
Why?
Pneumonia, Pneumocystis
1
2001
7
0.050
Why?
Lymphoma, Non-Hodgkin
1
2002
55
0.050
Why?
Microscopy, Electron
1
2001
77
0.050
Why?
Child
5
2015
6907
0.050
Why?
Immune Tolerance
1
2011
84
0.050
Why?
DNA Primers
2
1995
206
0.050
Why?
Foscarnet
1
2001
2
0.050
Why?
Tumor Cells, Cultured
2
1996
457
0.050
Why?
Ganciclovir
1
2001
25
0.050
Why?
Leukemia-Lymphoma, Adult T-Cell
1
2000
7
0.050
Why?
Cytomegalovirus
1
2001
28
0.040
Why?
Fatal Outcome
1
2001
197
0.040
Why?
Quality Control
3
2005
98
0.040
Why?
Antigens, Viral
1
2001
42
0.040
Why?
Chimera
1
1990
10
0.040
Why?
Isotonic Solutions
1
2010
17
0.040
Why?
Syndrome
1
2001
240
0.040
Why?
Anemia, Aplastic
1
1990
11
0.040
Why?
Neovascularization, Pathologic
1
2001
155
0.040
Why?
Transfection
3
1999
356
0.040
Why?
P-Selectin
1
2010
32
0.040
Why?
Virus Activation
1
2001
37
0.040
Why?
Sodium Chloride
1
2010
55
0.040
Why?
Angiogenesis Inhibitors
2
2007
183
0.040
Why?
Platelet Aggregation
1
2010
70
0.040
Why?
Algorithms
2
2005
631
0.040
Why?
Platelet Activation
1
2010
45
0.040
Why?
Predictive Value of Tests
2
2007
932
0.040
Why?
Hypersensitivity
1
2010
75
0.040
Why?
Peripheral Nervous System Diseases
1
1990
58
0.040
Why?
Polyomavirus
1
1989
3
0.040
Why?
Polymerase Chain Reaction
2
1995
449
0.040
Why?
Leukemia, Myeloid, Acute
2
2007
181
0.040
Why?
Antiviral Agents
1
2001
170
0.040
Why?
Cystitis
1
1989
18
0.040
Why?
Ultraviolet Rays
1
1989
49
0.040
Why?
Glucocorticoids
1
2000
230
0.040
Why?
Carrier Proteins
2
2004
298
0.040
Why?
Nitric Oxide Synthase Type II
1
2018
65
0.040
Why?
Pilot Projects
1
2000
702
0.040
Why?
DNA
1
1991
535
0.040
Why?
Ligands
1
2008
203
0.040
Why?
Arginase
1
2018
37
0.040
Why?
Polyethylene Glycols
1
2008
86
0.040
Why?
Hemoglobins
1
2008
109
0.040
Why?
Age Distribution
1
2007
171
0.040
Why?
Theophylline
1
2007
20
0.030
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.030
Why?
Multigene Family
1
2006
54
0.030
Why?
Chromosome Deletion
1
2007
134
0.030
Why?
In Situ Hybridization, Fluorescence
1
2007
231
0.030
Why?
Chromosome Mapping
1
2006
153
0.030
Why?
Apoptosis
1
2001
1097
0.030
Why?
Benzopyrenes
1
1975
2
0.030
Why?
3T3 Cells
1
1995
56
0.030
Why?
Epithelium
1
1975
66
0.030
Why?
Cytotoxicity, Immunologic
1
1995
55
0.030
Why?
Interleukin-2
1
1995
71
0.030
Why?
Cell Communication
1
2006
68
0.030
Why?
Interleukin-10
1
2006
84
0.030
Why?
Neoplasms, Experimental
1
2006
110
0.030
Why?
Liver
1
2001
1132
0.030
Why?
Life Tables
2
2002
9
0.030
Why?
Stroke Volume
1
2006
141
0.030
Why?
Ficoll
2
1996
2
0.030
Why?
Myocardial Ischemia
1
2006
114
0.030
Why?
Ventricular Dysfunction, Left
1
2006
106
0.030
Why?
Databases, Factual
1
2007
673
0.030
Why?
Mice, Transgenic
1
2006
540
0.030
Why?
Bromodeoxyuridine
1
2004
18
0.030
Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
33
0.030
Why?
Annexin A5
1
2004
14
0.030
Why?
Culture Media, Conditioned
1
2004
47
0.030
Why?
Epithelial Cells
1
1975
207
0.030
Why?
Immunotherapy
2
2002
235
0.030
Why?
Phagocytosis
1
2004
44
0.030
Why?
Survival Rate
1
2006
909
0.030
Why?
Fluorescent Antibody Technique, Indirect
1
2003
20
0.030
Why?
Syndecans
1
2003
37
0.030
Why?
Paraproteins
1
2003
13
0.030
Why?
Cell Division
1
2004
291
0.030
Why?
Chronic Disease
1
2006
574
0.030
Why?
Ifosfamide
2
1993
11
0.030
Why?
Syndecan-1
1
2003
75
0.030
Why?
Plasmapheresis
1
2003
11
0.030
Why?
Immunoenzyme Techniques
1
2003
137
0.030
Why?
Proteoglycans
1
2003
83
0.030
Why?
RANK Ligand
1
2004
187
0.030
Why?
Interleukin-6
1
2004
262
0.030
Why?
Severity of Illness Index
1
2006
978
0.030
Why?
Remission Induction
2
2003
208
0.030
Why?
Infusions, Intravenous
2
2003
213
0.030
Why?
NF-kappa B
1
2004
315
0.020
Why?
Drug Administration Schedule
2
2003
370
0.020
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.020
Why?
Blood Transfusion, Autologous
2
1992
6
0.020
Why?
Cell Differentiation
1
2004
640
0.020
Why?
Graft Rejection
1
2002
172
0.020
Why?
Colony-Forming Units Assay
2
1992
25
0.020
Why?
Disease Models, Animal
1
2006
1436
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
19
0.020
Why?
Drug Resistance, Neoplasm
2
2003
316
0.020
Why?
Interleukin-4
1
2010
42
0.020
Why?
Immunity, Cellular
1
2010
63
0.020
Why?
Adjuvants, Immunologic
1
2010
51
0.020
Why?
Magnetic Resonance Imaging
1
2007
1548
0.020
Why?
Biotechnology
1
1999
13
0.020
Why?
Child, Preschool
3
1994
3942
0.020
Why?
Immunologic Surveillance
1
1999
11
0.020
Why?
B-Lymphocytes
1
2010
171
0.020
Why?
Drug Resistance
1
1998
65
0.020
Why?
Steroids
1
1998
57
0.020
Why?
Chromatography, Gas
1
1998
15
0.020
Why?
Vaccination
1
2010
280
0.020
Why?
Secondary Prevention
1
1998
79
0.020
Why?
Neomycin
1
1997
4
0.020
Why?
Drug Resistance, Microbial
1
1997
45
0.020
Why?
Rats
2
1998
3292
0.020
Why?
Leukemia, Erythroblastic, Acute
1
1996
5
0.020
Why?
Stromal Cells
1
1997
75
0.020
Why?
Centrifugation, Density Gradient
1
1996
18
0.020
Why?
Solutions
1
1996
25
0.020
Why?
Indicators and Reagents
1
1996
37
0.020
Why?
Clone Cells
1
2006
70
0.020
Why?
Deoxycytidine
1
2006
30
0.020
Why?
Temperature
1
1996
163
0.020
Why?
Genes
1
1995
32
0.020
Why?
Transduction, Genetic
1
1995
46
0.020
Why?
In Situ Hybridization
1
1995
66
0.020
Why?
Chromatography, Affinity
1
1995
39
0.020
Why?
Fluorouracil
1
1995
58
0.020
Why?
Genes, Reporter
1
1995
88
0.020
Why?
Genetic Markers
1
1995
104
0.020
Why?
Recovery of Function
1
2006
191
0.010
Why?
Mice, Inbred BALB C
1
1995
296
0.010
Why?
Lymphocyte Subsets
1
1994
14
0.010
Why?
Kinetics
1
2006
623
0.010
Why?
Macaca mulatta
1
1994
97
0.010
Why?
Propidium
1
1994
3
0.010
Why?
T-Lymphocyte Subsets
1
1994
39
0.010
Why?
Immunophenotyping
1
1994
105
0.010
Why?
Mutation
1
1999
1280
0.010
Why?
Oligodeoxyribonucleotides
1
1993
33
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
Confidence Intervals
1
2003
154
0.010
Why?
Cell Death
1
1994
175
0.010
Why?
Probability
1
2003
164
0.010
Why?
Cell Nucleus
1
1994
182
0.010
Why?
Data Interpretation, Statistical
1
1994
163
0.010
Why?
Leukocyte Count
1
2003
69
0.010
Why?
Academic Medical Centers
1
1994
149
0.010
Why?
Carboplatin
1
1992
54
0.010
Why?
Multiple Organ Failure
1
2002
48
0.010
Why?
Neoplasm Metastasis
1
1993
232
0.010
Why?
Injections, Intravenous
1
1992
137
0.010
Why?
Statistics as Topic
1
1992
89
0.010
Why?
Administration, Oral
1
2003
434
0.010
Why?
Leukopenia
1
1992
8
0.010
Why?
Blood Cell Count
1
1992
39
0.010
Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
45
0.010
Why?
Doxorubicin
1
2003
236
0.010
Why?
Linear Models
1
1992
279
0.010
Why?
Proportional Hazards Models
1
1992
415
0.010
Why?
Neoplasm Staging
1
2003
746
0.010
Why?
Pedigree
1
1990
119
0.010
Why?
HLA Antigens
1
1990
52
0.010
Why?
Bacterial Infections
1
1991
95
0.010
Why?
Muscle Cramp
1
1990
6
0.010
Why?
Mycoses
1
1991
155
0.010
Why?
Software
1
1992
278
0.010
Why?
Postoperative Period
1
1990
171
0.010
Why?
Sepsis
1
2002
225
0.010
Why?
Disease Progression
1
2003
829
0.010
Why?
Busulfan
1
1989
19
0.010
Why?
Tumor Virus Infections
1
1989
47
0.010
Why?
Hematopoiesis
1
1989
72
0.010
Why?
Dose-Response Relationship, Radiation
1
1989
183
0.010
Why?
Glycols
1
1975
3
0.010
Why?
Quinones
1
1975
9
0.010
Why?
Hydrocortisone
1
1975
110
0.010
Why?
Phenols
1
1975
82
0.010
Why?
Microsomes, Liver
1
1975
183
0.010
Why?
Fibroblasts
1
1975
336
0.010
Why?
Cells, Cultured
1
1975
1571
0.010
Why?
Infant
1
1990
3630
0.010
Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description